Why the study?
Doxorubicin efficacy is limited by severe cardiotoxicity involving ferroptosis, but the role and molecular mechanism of resveratrol in doxorubicin-mediated ferroptosis in cardiomyocytes remain unclear.
Does resveratrol prevent doxorubicin-induced ferroptosis and cardiotoxicity in cardiomyocytes and mice?
Does resveratrol prevent doxorubicin-induced ferroptosis and cardiotoxicity in cardiomyocytes and mice?
Resveratrol protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via activation of the p62-NRF2 axis.
Answers are grounded in this paper and cite their sources.
RSV may modulate DOX ferroptosis in vitro; leaves open clinical cardioprotection during anthracycline therapy.
Doxorubicin (DOX) is a most common anthracycline chemotherapeutic agent; however, its clinical efficacy is limited due to its severe and irreversible cardiotoxicity. Ferroptosis, characterized by iron overload and lipid peroxidation, plays a pivotal role in DOX-induced cardiotoxicity. Resveratrol (RSV) displays cardioprotective and anticancer effects, owing to its antioxidative and anti-inflammatory properties. However, the role and mechanism of RSV in DOX-mediated ferroptosis in cardiomyocytes is unclear. This study showed that DOX decreased cell viability, increased iron accumulation and lipid peroxidation in H9c2 cells; however, these effects were reversed by RSV and ferroptosis inhibitor ferrostatin-1 (Fer-1) pre-treatment. Additionally, RSV significantly increased the cell viability of H9c2 cells treated with ferroptosis inducers Erastin (Era) and RSL3. Mechanistically, RSV inhibited mitochondrial reactive oxygen species (mtROS) overproduction and upregulated the p62-NRF2/HO-1 pathway. RSV-induced NRF2 activation was partially dependent on p62, and the selective inhibition of p62 (using p62-siRNA interference) or NRF2 (using NRF2 specific inhibitor, ML385) significantly abolished the anti-ferroptosis function of RSV. Furthermore, RSV treatment protected mice against DOX-induced cardiotoxicity, including significantly improving left ventricular function, ameliorating myocardial fibrosis and suppressing ferroptosis. Consistent with in vitro results, RSV also upregulated the p62-NRF2/HO-1 expression, which was inhibited by DOX, in the myocardium. Notably, the protective effect of RSV in DOX-mediated ferroptosis was similar to that of Fer-1 in vitro and in vivo. Thus, the p62-NRF2 axis plays a critical role in regulating DOX-induced ferroptosis in cardiomyocytes. RSV as a potent p62 activator has potential as a therapeutic target in preventing DOX-induced cardiotoxicity via ferroptosis modulation.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: